rs8176218

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_007294.4(BRCA1):​c.4676-284_4676-283insACAAGCATTGTTACAGTGAACATT variant causes a intron change involving the alteration of a non-conserved nucleotide. It is difficult to determine the true allele frequency of this variant because it is of type INS_BIG, and the frequency of such variant types in population databases may be underestimated and unreliable. Variant has been reported in ClinVar as Benign (★★★).

Frequency

Genomes: 𝑓 0.32 ( 7961 hom., cov: 0)

Consequence

BRCA1
NM_007294.4 intron

Scores

Not classified

Clinical Significance

Benign reviewed by expert panel B:2

Conservation

PhyloP100: -0.489

Publications

6 publications found
Variant links:
Genes affected
BRCA1 (HGNC:1100): (BRCA1 DNA repair associated) This gene encodes a 190 kD nuclear phosphoprotein that plays a role in maintaining genomic stability, and it also acts as a tumor suppressor. The BRCA1 gene contains 22 exons spanning about 110 kb of DNA. The encoded protein combines with other tumor suppressors, DNA damage sensors, and signal transducers to form a large multi-subunit protein complex known as the BRCA1-associated genome surveillance complex (BASC). This gene product associates with RNA polymerase II, and through the C-terminal domain, also interacts with histone deacetylase complexes. This protein thus plays a role in transcription, DNA repair of double-stranded breaks, and recombination. Mutations in this gene are responsible for approximately 40% of inherited breast cancers and more than 80% of inherited breast and ovarian cancers. Alternative splicing plays a role in modulating the subcellular localization and physiological function of this gene. Many alternatively spliced transcript variants, some of which are disease-associated mutations, have been described for this gene, but the full-length natures of only some of these variants has been described. A related pseudogene, which is also located on chromosome 17, has been identified. [provided by RefSeq, May 2020]
BRCA1 Gene-Disease associations (from GenCC):
  • breast-ovarian cancer, familial, susceptibility to, 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Fanconi anemia, complementation group S
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics
  • pancreatic cancer, susceptibility to, 4
    Inheritance: AD Classification: MODERATE Submitted by: Genomics England PanelApp
  • hereditary breast ovarian cancer syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 17-43071521-G-GAATGTTCACTGTAACAATGCTTGT is Benign according to our data. Variant chr17-43071521-G-GAATGTTCACTGTAACAATGCTTGT is described in ClinVar as Benign. ClinVar VariationId is 264795.Status of the report is reviewed_by_expert_panel, 3 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.476 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_007294.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
NM_007294.4
MANE Select
c.4676-284_4676-283insACAAGCATTGTTACAGTGAACATT
intron
N/ANP_009225.1
BRCA1
NM_001407581.1
c.4742-284_4742-283insACAAGCATTGTTACAGTGAACATT
intron
N/ANP_001394510.1
BRCA1
NM_001407582.1
c.4742-284_4742-283insACAAGCATTGTTACAGTGAACATT
intron
N/ANP_001394511.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BRCA1
ENST00000357654.9
TSL:1 MANE Select
c.4676-284_4676-283insACAAGCATTGTTACAGTGAACATT
intron
N/AENSP00000350283.3
BRCA1
ENST00000471181.7
TSL:1
c.4739-284_4739-283insACAAGCATTGTTACAGTGAACATT
intron
N/AENSP00000418960.2
BRCA1
ENST00000470026.6
TSL:1
c.4676-284_4676-283insACAAGCATTGTTACAGTGAACATT
intron
N/AENSP00000419274.2

Frequencies

GnomAD3 genomes
AF:
0.317
AC:
48127
AN:
151834
Hom.:
7955
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.235
Gnomad AMI
AF:
0.285
Gnomad AMR
AF:
0.328
Gnomad ASJ
AF:
0.358
Gnomad EAS
AF:
0.371
Gnomad SAS
AF:
0.493
Gnomad FIN
AF:
0.404
Gnomad MID
AF:
0.354
Gnomad NFE
AF:
0.332
Gnomad OTH
AF:
0.333
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.317
AC:
48161
AN:
151952
Hom.:
7961
Cov.:
0
AF XY:
0.323
AC XY:
24013
AN XY:
74272
show subpopulations
African (AFR)
AF:
0.235
AC:
9728
AN:
41412
American (AMR)
AF:
0.329
AC:
5015
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.358
AC:
1243
AN:
3468
East Asian (EAS)
AF:
0.370
AC:
1917
AN:
5180
South Asian (SAS)
AF:
0.492
AC:
2366
AN:
4808
European-Finnish (FIN)
AF:
0.404
AC:
4255
AN:
10542
Middle Eastern (MID)
AF:
0.354
AC:
104
AN:
294
European-Non Finnish (NFE)
AF:
0.332
AC:
22562
AN:
67972
Other (OTH)
AF:
0.337
AC:
712
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1592
3185
4777
6370
7962
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
498
996
1494
1992
2490
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.306
Hom.:
894
Asia WGS
AF:
0.417
AC:
1447
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Breast-ovarian cancer, familial, susceptibility to, 1 Benign:1
Sep 28, 2016
Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

Class 1 not pathogenic based on frequency >1% in an outbred sampleset. Frequency 0.3598 (European), 0.2209 (African), 0.3746 (Admixed American/Latino), 0.372 (East Asian), 0.498 (South Asian), derived from 1000 genomes (2013-05-02).

not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.49
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs8176218; hg19: chr17-41223538; API